Search | Médecins Sans Frontières Access Campaign

20 results found
There is 1 active filter
Clear all filters
Bayer

20 results found

Press release |

15 December 2014

MSF responds to Indian Supreme Court decision upholding production of affordable cancer drug

Tags Intellectual property and trade nexavar Bayer India

Opinion article |

02 October 2014

Dear Prime Minister Modi: Stand Firm for Affordable Medicines

Tags Bayer

Statement |

31 January 2014

MSF responds to news of pull out of neglected disease R&D by AstraZeneca

Tags Research and development malarianeglected diseasestuberculosis research and development (R&D) BayerPHARMACEUTICAL CompaniesAstraZeneca

Statement |

23 January 2014

MSF response to Bayer CEO statement that medicines developed only for western patients

Tags Intellectual property and trade research and development (R&D) Bayer India

Hundreds of Indian activists protested in New Delhi on Monday against a challenge to the country's patent law by Swiss pharmaceutical giant Novartis.

Press release |

25 September 2013

U.S. Puts Unwarranted Pressure on India for Taking Legal Steps to Increase Access to Affordable Medicines

Tags Intellectual property and trade Bayer India

Opinion article |

28 March 2013

BBC: Do drugs really have to be so expensive?

Tags Intellectual property and tradeResearch and development compulsory licenceresearch and development (R&D) Bayer India

Statement |

04 March 2013

India upholds compulsory licence on cancer drug in Bayer case appeal

Tags Intellectual property and trade compulsory licence Bayer India

Statement |

18 January 2013

Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug

Tags Intellectual property and trade raltegravir compulsory licenceTRIPS Bayer India

Statement |

17 September 2012

MSF statement on India's dismissal of Bayer's request for a stay on compulsory licence

Tags Intellectual property and trade compulsory licence Bayer India

Infographic |

11 September 2012

Infographics: Big pharma's continued attack on India, 'pharmacy of the developing world'

Tags HIV/AIDSIntellectual property and trade NovartisBayer Novartis Drop the Case Campaign India

Statement |

05 September 2012

Bayer compulsory licence hearing concludes - judgment awaited

Tags Intellectual property and trade compulsory licence Bayer India

Infographic

Big pharma charges unaffordable prices for medicines in India

Tags BayerNovartis India

Press release |

03 September 2012

Bayer attempts block on affordable patented drugs in India

Tags Intellectual property and trade raltegravirantiretroviral medicines compulsory licence Bayer India

Feature story |

22 August 2012

Update: Intellectual Property Battles Continue in India; Novartis Trial Further Delayed

Tags HIV/AIDSIntellectual property and trade compulsory licence Bayer Novartis Drop the Case Campaign India

Statement |

21 August 2012

Bayer/Natco compulsory licence appeal – hearings postponed

Tags Intellectual property and trade HIV/AIDS compulsory licence Bayer India

Feature story |

10 April 2012

Background Information on India's First Compulsory Licence

Tags Intellectual property and trade compulsory licence Bayer India

Opinion article |

19 April 2010

India: Will Pharma, trade agreements shut down the Pharmacy of the Developing World?

Tags Intellectual property and trade free trade agreement Bayer India

Press release |

09 February 2010

Indian Court Gives Boost to Access to Medicines As Latest Appeal By Bayer is Rejected

Tags Intellectual property and trade Bayer

Feature story |

09 February 2010

Victory for access to medicines as Bayer loses lawsuit in India

Tags Intellectual property and trade Bayer

Press release |

15 May 2009

NECT Added to WHO Essential Medicines List as Combination Treatment Against Sleeping Sickness

Tags Tropical & neglected diseases sleeping sickness BayerDNDiWorld Health Organization

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF responds to Indian Supreme Court decision upholding production of affordable cancer drug

Dear Prime Minister Modi: Stand Firm for Affordable Medicines

MSF responds to news of pull out of neglected disease R&D by AstraZeneca

MSF response to Bayer CEO statement that medicines developed only for western patients

U.S. Puts Unwarranted Pressure on India for Taking Legal Steps to Increase Access to Affordable Medicines

BBC: Do drugs really have to be so expensive?

India upholds compulsory licence on cancer drug in Bayer case appeal

Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug

MSF statement on India's dismissal of Bayer's request for a stay on compulsory licence

Infographics: Big pharma's continued attack on India, 'pharmacy of the developing world'

Bayer compulsory licence hearing concludes - judgment awaited

Big pharma charges unaffordable prices for medicines in India

Bayer attempts block on affordable patented drugs in India

Update: Intellectual Property Battles Continue in India; Novartis Trial Further Delayed

Bayer/Natco compulsory licence appeal – hearings postponed

Background Information on India's First Compulsory Licence

India: Will Pharma, trade agreements shut down the Pharmacy of the Developing World?

Indian Court Gives Boost to Access to Medicines As Latest Appeal By Bayer is Rejected

Victory for access to medicines as Bayer loses lawsuit in India

NECT Added to WHO Essential Medicines List as Combination Treatment Against Sleeping Sickness